WOLF — Grey Wolf Animal Health Share Price
- CA$22.03m
- CA$24.17m
- CA$25.41m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.88 | ||
Price to Tang. Book | 13.15 | ||
Price to Free Cashflow | 10.25 | ||
Price to Sales | 0.87 | ||
EV to EBITDA | 8.03 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 4.54% | ||
Return on Equity | 2.47% | ||
Operating Margin | 6.12% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | n/a | n/a | 13.1 | 22.64 | 25.41 | n/a | n/a | 39.3% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | -76.03 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Grey Wolf Animal Health Corp. is a Canada-based animal health and wellness company. It has a portfolio of products that meets the unmet needs of veterinarians, clinics, and pets. Its segments include the animal health business unit and the pharmacy business unit. The animal health business unit segment primarily focuses on selling, marketing, and distributing pharmaceutical, nutraceutical and consumable products to veterinary clinics across Canada. The pharmacy business unit segment compounds pharmaceuticals, primarily for equine use but also for the bioidentical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients. Its product categories include companion animals and equine health. The companion animals product category includes wound care, nutraceuticals, and others. It focuses on in-licensing, acquiring, or developing prescription and non-prescription products for commercialization in the veterinarian channel in Canada.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 9th, 2021
- Public Since
- June 17th, 2021
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 31,032,222
- Address
- 65 Front Street East, Suite 201, Toronto, M5E 1B5
- Web
- https://greywolfah.com/
- Phone
- +1 4164812222
- Auditors
- PWC
Upcoming Events for WOLF
Similar to WOLF
BuildDirect.com Technologies
TSX Venture Exchange
Friday's Dog Holdings
TSX Venture Exchange
Reitmans Canada
TSX Venture Exchange
FAQ
As of Today at 19:09 UTC, shares in Grey Wolf Animal Health are trading at CA$0.71. This share price information is delayed by 15 minutes.
Shares in Grey Wolf Animal Health last closed at CA$0.71 and the price had moved by -48.57% over the past 365 days. In terms of relative price strength the Grey Wolf Animal Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -51.2% over the past year.
There is no consensus recommendation for this security.
Grey Wolf Animal Health does not currently pay a dividend.
Grey Wolf Animal Health does not currently pay a dividend.
Grey Wolf Animal Health does not currently pay a dividend.
To buy shares in Grey Wolf Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.71, shares in Grey Wolf Animal Health had a market capitalisation of CA$22.03m.
Here are the trading details for Grey Wolf Animal Health:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: WOLF
Based on an overall assessment of its quality, value and momentum Grey Wolf Animal Health is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Grey Wolf Animal Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -50.35%.
As of the last closing price of CA$0.71, shares in Grey Wolf Animal Health were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Grey Wolf Animal Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Grey Wolf Animal Health's directors